GC protein-derived macrophage-activating factor decreases α-N-acetylgalactosaminidase levels in advanced cancer patients

References

• Yamamoto N, Naraparaju VR, Moore M, Brent LH. Deglycosylation of serum vitamin D3-binding protein by alpha-N-acetylgalactosaminidase detected in the plasma of patients with systemic lupus erythematosus. Clin Immunol Immunopathol 1997; 82:290 - 8; http://dx.doi.org/10.1006/clin.1996.4320; PMID: 9073553
   PubMedGoogle Scholar
• Mohamad SB, Nagasawa H, Uto Y, Hori H. Tumor cell alpha-N-acetylgalactosaminidase activity and its involvement in GcMAF-related macrophage activation. Comp Biochem Physiol A Mol Integr Physiol 2002; 132:1 - 8; http://dx.doi.org/10.1016/S1095-6433(01)00522-0; PMID: 12062184
   PubMed Web of Science ®Google Scholar
• Greco M, Mitri MD, Chiriacò F, Leo G, Brienza E, Maffia M. Serum proteomic profile of cutaneous malignant melanoma and relation to cancer progression: association to tumor derived alpha-N-acetylgalactosaminidase activity. Cancer Lett 2009; 283:222 - 9; http://dx.doi.org/10.1016/j.canlet.2009.04.001; PMID: 19394758
   PubMed Web of Science ®Google Scholar
• Reddi AL, Sankaranarayanan K, Arulraj HS, Devaraj N, Devaraj H. Serum alpha-N-acetylgalactosaminidase is associated with diagnosis/prognosis of patients with squamous cell carcinoma of the uterine cervix. Cancer Lett 2000; 158:61 - 4; http://dx.doi.org/10.1016/S0304-3835(00)00502-4; PMID: 10940510
   PubMed Web of Science ®Google Scholar
• Yamamoto N, Suyama H, Yamamoto N, Ushijima N. Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor (GcMAF). Int J Cancer 2008; 122:461 - 7; http://dx.doi.org/10.1002/ijc.23107; PMID: 17935130
   PubMed Web of Science ®Google Scholar
• Yamamoto N, Suyama H, Nakazato H, Yamamoto N, Koga Y. Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF. Cancer Immunol Immunother 2008; 57:1007 - 16; http://dx.doi.org/10.1007/s00262-007-0431-z; PMID: 18058096
   PubMed Web of Science ®Google Scholar
• Yamamoto N, Suyama H, Yamamoto N. Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF. Transl Oncol 2008; 1:65 - 72; PMID: 18633461
   PubMed Web of Science ®Google Scholar
• Nonaka K, Onizuka S, Ishibashi H, Uto Y, Hori H, Nakayama T, et al. Vitamin D binding protein-macrophage activating factor inhibits HCC in SCID mice. J Surg Res 2012; 172:116 - 22; http://dx.doi.org/10.1016/j.jss.2010.07.057; PMID: 20855083
   PubMed Web of Science ®Google Scholar
• Gregory KJ, Zhao B, Bielenberg DR, Dridi S, Wu J, Jiang W, et al. Vitamin D binding protein-macrophage activating factor directly inhibits proliferation, migration, and uPAR expression of prostate cancer cells. PLoS One 2010; 5:e13428; http://dx.doi.org/10.1371/journal.pone.0013428; PMID: 20976141
   PubMed Web of Science ®Google Scholar
• Pacini S, Punzi T, Morucci G, Gulisano M, Ruggiero M. Effects of vitamin D-binding protein-derived macrophage-activating factor on human breast cancer cells. Anticancer Res 2012; 32:45 - 52; PMID: 22213287
   PubMed Web of Science ®Google Scholar
• Kalkunte S, Brard L, Granai CO, Swamy N. Inhibition of angiogenesis by vitamin D-binding protein: characterization of anti-endothelial activity of DBP-maf. Angiogenesis 2005; 8:349 - 60; http://dx.doi.org/10.1007/s10456-005-9024-7; PMID: 16400520
   PubMedGoogle Scholar
• Pacini S, Morucci G, Punzi T, Gulisano M, Ruggiero M. Gc protein-derived macrophage-activating factor (GcMAF) stimulates cAMP formation in human mononuclear cells and inhibits angiogenesis in chick embryo chorionallantoic membrane assay. Cancer Immunol Immunother 2011; 60:479 - 85; http://dx.doi.org/10.1007/s00262-010-0953-7; PMID: 21170647
   PubMed Web of Science ®Google Scholar
• Pacini S, Morucci G, Punzi T, Gulisano M, Ruggiero M, Amato M, et al. Effect of paricalcitol and GcMAF on angiogenesis and human peripheral blood mononuclear cell proliferation and signaling. J Nephrol 2012; 25:577 - 81; http://dx.doi.org/10.5301/jn.5000035; PMID: 21956771
   PubMed Web of Science ®Google Scholar
• Yamamoto N, Naraparaju VR, Urade M. Prognostic utility of serum alpha-N-acetylgalactosaminidase and immunosuppression resulted from deglycosylation of serum Gc protein in oral cancer patients. Cancer Res 1997; 57:295 - 9; PMID: 9000571
   PubMed Web of Science ®Google Scholar
• Yamamoto N, Lindsay DD, Naraparaju VR, Ireland RA, Popoff SN. A defect in the inflammation-primed macrophage-activation cascade in osteopetrotic rats. J Immunol 1994; 152:5100 - 7; PMID: 8176226
   PubMed Web of Science ®Google Scholar
• Nunn R. Mere anecdote: evidence and stories in medicine. J Eval Clin Pract 2011; 17:920 - 6; http://dx.doi.org/10.1111/j.1365-2753.2011.01727.x; PMID: 21815971
   PubMed Web of Science ®Google Scholar
• Yamamoto N, Ushijima N, Koga Y. Immunotherapy of HIV-infected patients with Gc protein-derived macrophage activating factor (GcMAF). J Med Virol 2009; 81:16 - 26; http://dx.doi.org/10.1002/jmv.21376; PMID: 19031451
   PubMed Web of Science ®Google Scholar
• Bradstreet JJ, Vogelaar E, Thyer L. Initial observations of elevated alpha-N-acetylgalactosaminidase activity associated with autism and observed reductions from GC protein-macrophage activating factor injections. Autism Insights 2012; 4:31 - 8; http://dx.doi.org/10.4137/AUI.S10485
   Google Scholar
• Fabris A, Biagioni P, Punzi T, Morucci G, Gulisano M, Pacini S, et al. Role of angiotensin-converting enzyme and vitamin D receptor gene polymorphisms in cancer anorexia-cachexia syndrome. Am J Immunol 2012; 8:65 - 70
   Google Scholar
• Rehder DS, Nelson RW, Borges CR. Glycosylation status of vitamin D binding protein in cancer patients. Protein Sci 2009; 18:2036 - 42; http://dx.doi.org/10.1002/pro.214; PMID: 19642159
   PubMed Web of Science ®Google Scholar
• Inui T, Kuchiike D, Kubo K, Mette M, Uto Y, Hori H, et al. Clinical Experience of Integrative Cancer Immunotherapy with GcMAF. Anticancer Res 2013; 33:2917 - 9; PMID: 23780980
   PubMed Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248 - 54; http://dx.doi.org/10.1016/0003-2697(76)90527-3; PMID: 942051
   PubMed Web of Science ®Google Scholar